bioRxiv Science⌕ Search

bioRxiv · 10.1101/710699

Termin(A)ntor: Polyadenylation Site Prediction using deep learning models

Abstract

As a widespread RNA processing machinery, alternative polyadenylation plays a crucial role in gene regulation. To help decipher its underlying mechanism and understand its impact, it is desirable to comprehensively profile 3-untranslated region cleavage and associated polyadenylation sites. State-of-the-art polyadenylation site detection tools are known to be influenced by library preparation artefacts or manually selected features. Moreover, recently published machine learning methods have only been tested on pre-constructed datasets, thus lacking validation on experimental data. Here we present Terminitor, the first deep neural network-based profiling pipeline to make predictions from RNA-seq data. We show how Terminitor outperforms competing tools in sensitivity and precision on experimental transcriptome sequencing data, and demonstrate its use with data from short- and long-read sequencing technologies. For species without a good reference transcriptome annotation, Terminitor is still able to pass on the information learnt from a related species and make reasonable predictions. We used Terminitor to showcase how single nucleotide variations can create or destroy polyadenylated cleavage sites in human RNA-seq samples. Author Summary3 cleavage and polyadenylation of pre-mRNA is part of RNA maturation process. One gene can be cleaved at different positions at its 3 end, namely alternatively polyadenylation, thus identifying the correct polyadenylated cleavage site (poly(A) CS) is essential to unveil its role in gene regulation under different physiological and pathological conditions. The current poly(A) CS prediction tools are either heavily influenced by RNA-Seq library preparation artefacts or have only been designed and tested on ad hoc datasets, lacking association with real world applications. In this study, we present a deep learning model, Terminitor, that predicts the probability of a nucleotide sequence containing a poly(A) CS, and validated its performance on human and mouse data. Along with the model, we propose a poly(A) CS profiling pipeline for RNA-seq data. We benchmarked our pipeline against competing tools and achieved higher sensitivity and precision in experimental data. The usage of Terminitor is not limited to genome and transcriptome annotation and we expect it to facilitate the identification of novel isoforms, improve the accuracy of transcript quantification and differential expression analysis, and contribute to the repertoire of reference transcriptome annotation.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yang, C., Li, C., Nip, K. M., Warren, R. L., Birol, I.. 2019-07-22. Termin(A)ntor: Polyadenylation Site Prediction using deep learning models. https://doi.org/10.1101/710699

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Accelerating discovery and integration from RNA to Protein with R2T2P

Integrating transcriptomics and proteomics data remains an unmet challenge in the post-genomics era, discouraging researchers from pursuing integrative approaches to molecular biology research. Leveraging the power of translation profiling, we present RNA to Translation to Protein (R2T2P), a computational platform integrating genome-guided transcriptome assembly with identification of translation and proteins, including a tailored differential analysis framework and support for multiple reference transcriptomes. We applied R2T2P to investigate a cellular model of facioscapulohumeral muscular dystrophy (FSHD), where ectopic expression of the DUX4 retrogene in skeletal muscle triggers significant alterations in transcription and RNA metabolism. We uncovered hundreds of uncharacterized, highly overexpressed RNAs, including antisense and alternative transcripts, and quantified their contribution to translatome and proteome. Re-analysis of expression datasets from patient-derived myotubes and muscle biopsies validated this alternative transcriptome in FSHD patients, adding a reservoir of bona-fide novel molecular actors in a rare disease. Available at https://github.com/nfdata-omics/R2T2P/, R2T2P is a flexible and powerful workflow in modern integrative biology.

bioinformatics↗

MorphoANOVA: Dissecting Histology-Gene Expression Relationships in Spatial Transcriptomics

Spatial transcriptomics (ST) measures the expression of hundreds to thousands of genes within tissue architecture, often accompanied by histology images. However, it remains challenging to systematically characterize which genes exhibit associations with tissue morphology, whether these associations vary spatially, and which genes show additional spatial expression patterns beyond those captured by morphology. Here we introduce MorphoANOVA, a gene-wise statistical framework for characterizing morphology--expression relationships across genes measured by ST. Using nested spatially varying coefficient models and sequential ANOVA, MorphoANOVA assesses slide-wide associations with an H\&E-derived morphology feature, location-specific changes in these associations, and additional spatial variation after accounting for the selected feature. The resulting statistics enable gene prioritization and pathway enrichment analysis, while spatial component maps support the interpretation of individual genes. Simulations demonstrate MorphoANOVA's ability to distinguish the modeled components and recover their spatial patterns. Applications to human cortex and breast cancer identify biological programs associated with different morphology--expression patterns and reveal distinct relationships with cell composition. Across three HER2-positive breast cancer patients, invasive-cancer marker genes consistently exhibit stronger evidence of location-specific morphology associations. MorphoANOVA thus provides a framework for systematically interpreting spatial gene-expression patterns in relation to tissue morphology.

bioinformatics↗

Evaluation effects can rival reported concordance gains in cross-cancer survival prediction

Studies of cross-cancer learning for survival prediction from tumour omics have reported concordance gains of 0.020 and 0.045, but how such gains compare with evaluation effects remains unclear. We examined these effects across 13 TCGA cancers (5,761 patients, 1,526 disease-specific deaths), using five repeats of five-fold cross-validation and paired bootstrap intervals. When model selection did not use test data, our borrowing model gained 0.009 (95% interval 0.001 to 0.016) over its target-fitted reference when cancers received equal weight (post hoc). Random-effects pooling gave a gain of 0.002 (-0.002 to 0.006), with most weight assigned to cancers where the model made little use of the pretrained score. Choosing the fusion weight on test splits raised the apparent equal-weight gain to 0.017. We reimplemented a published method, VAECox, which showed no pretraining gain over random initialisation at the last or validation-selected training step. Choosing each network's best test step, as the published code does, raised concordance by 0.03 to 0.05 across the 13-cancer and ten-cancer overall-survival settings, but barely changed the difference between networks. In a constructed post hoc experiment, choosing the best test step only for the pretrained network changed the equal-weight mean difference from -0.004 to +0.045 (+0.035 to +0.054). Across seven multi-omics comparisons, estimates from single five-fold runs differed from their cancer's five-run mean by at least 0.02 in 11% to 42% of runs. Concordance was about 0.02 lower at held-out tissue source sites. Interpreting a reported gain therefore requires each model's selection rule, variation across repeated partitions, the weighting of cancers and the evaluation population.

bioinformatics↗